ICON8: A GCIG phase III randomised trial evaluating weekly dosedense chemotherapy integration in first- line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: Results of primary progression- free survival (PFS) analysis
Egile Nagusiak: | , , , , , , , , , , , , , , , , , , |
---|---|
Formatua: | Conference item |
Argitaratua: |
Oxford University Press
2017
|